tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
Advertisement

Immunovant (IMVT) Similar Stocks

Compare
843 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immunovant
$16.95
$2.90B
-41.73%
8 Buy
3 Hold
0 Sell
Moderate Buy
Protagonist Therapeutics
$55.15
$3.42B
72.50
42.10%
9 Buy
0 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$30.99
$2.90B
-42.89%
10 Buy
1 Hold
0 Sell
Strong Buy
Mirum Pharmaceuticals
$51.83
$2.57B
23.26%
7 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$45.79
$3.21B
4.93%
17 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$55.07
$3.54B
27.68%
11 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMVT
Immunovant
16.95
-12.14
-41.73%
PTGX
Protagonist Therapeutics
55.15
16.34
42.10%
CRNX
Crinetics Pharmaceuticals
30.99
-23.27
-42.89%
MIRM
Mirum Pharmaceuticals
51.83
9.78
23.26%
KYMR
Kymera Therapeutics
45.79
2.15
4.93%
MLTX
MoonLake Immunotherapeutics
55.07
11.94
27.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis